Navigation Links
Bedford Laboratories™ Issues Nationwide Voluntary Recall of Cytarabine for Injection, USP, 1 Gram Per Vial
Date:2/16/2012

BEDFORD, Ohio, Feb. 16, 2012 /PRNewswire/ -- Bedford Laboratories™ announces a nationwide voluntary recall for the following three lots of Cytarabine for Injection, USP:

Cytarabine for Injection, USP 1 gram per vial – NDC #55390-133-01

  • Lot 2066986 – Exp. Date March 31, 2014
  • Lot 2111675 – Exp. Date December 31, 2013
  • Lot 2131148 – Exp. Date May 31, 2014

(Logo: http://photos.prnewswire.com/prnh/20070809/CLTH157LOGO )

This voluntary market recall is being conducted due to a post-release investigation of the manufacturing area which determined a potential elevated risk of a lack of sterility assurance for these specific lots.  To date, there have been no reports of any adverse events for the lots being recalled. 

Cytarabine in combination with other approved anticancer drugs is indicated for remission induction in acute non-lymphocytic leukemia of adults and children. It has also been found useful in the treatment of acute lymphocytic leukemia and the blast phase of chronic myelocytic leukemia. Intrathecal administration of cytarabine is indicated in the prophylaxis and treatment of meningeal leukemia.

Initial recall notification of the Cytarabine for Injection lots listed above were sent to impacted wholesalers and distributors by overnight courier and arranged for return of all recalled product.  Hospitals, emergency rooms, clinics, physician offices and other healthcare facilities and providers should not use the product lots listed above for patient care and should immediately quarantine any product for return.  Should wholesalers/distributors/retailers still have product which is being recalled, they should stop use and contact Bedford Laboratories Client Services at 800.562.4797. 

Bedford Laboratories has informe
'/>"/>

SOURCE Bedford Laboratories
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Bedford Laboratories(TM) To Begin Shipping Fluconazole Injection
2. Bedford Laboratories(TM) First To Manufacture Generic Indomethacin for Injection USP
3. Bedford Laboratories™ to Begin Shipping Dactinomycin for Injection USP 500 mcg (0.5 mg)
4. Bedford Laboratories™ to Begin Shipping Topotecan Hydrochloride for Injection, 4mg SD Vial
5. Sagard Capital Increases Ownership in GP Strategies by 350,000 Shares in a Private Transaction with Bedford Oak Partners, L.P.
6. Bedford Laboratories™ Issues Guidance on 2011 Voluntary Recall of Polymyxin B for Injection USP and Vecuronium Bromide for Injection Related to Glass Particulates
7. The First Annual Cervical Cancer/HPV Conference Tackles Controversial Vaccine Issues and Encourages Advocacy
8. European Unions CHMP Issues Positive Opinion on PEGINTRON(TM) Combination Therapy for Retreating Hepatitis C Patients Who Failed Previous Therapy
9. European CHMP Issues Positive Opinion for ATRIPLA(R) (efavirenz 600 mg/ emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg)
10. Bayer Issues Additional Guidance to Physicians on Trasylol(R)
11. Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on CEL-SCI Corporation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/26/2014)... NORTH ANDOVER, Mass. , Aug. 26, 2014 ... and Eatontown, N.J ., is expanding.  ... & Fitness to form a new division, Acelleron Maternal Health ... to their clients by providing a full range of resources ... Vecchi has been named the director of maternal wellness. ...
(Date:8/26/2014)...  Royal Philips (NYSE: PHG, AEX: PHIA) introduces the ... to empower seniors to live independently while aging well. ... call center, the mobile app gives seniors 24-hour access ... Philips and the Global Social Enterprise Initiative (GSEI) ... 96 percent of senior respondents said it is important ...
(Date:8/26/2014)... 2014  Avanir Pharmaceuticals, Inc. (NASDAQ: ... first patient into a phase II study to ... for the adjunctive treatment of major depressive disorder ... of a combination of deuterium modified dextromethorphan and ... of people with MDD who remain depressed despite ...
Breaking Medicine Technology:Suzanne Vecchi Named Director of Newly Acquired Acelleron Maternal Health & Wellness 2Philips Lifeline introduces response app to connect seniors with access to help in the event of an emergency 2Philips Lifeline introduces response app to connect seniors with access to help in the event of an emergency 3Avanir Pharmaceuticals Announces Initiation of Phase II Study of AVP-786 for the Adjunctive Treatment of Major Depressive Disorder 2Avanir Pharmaceuticals Announces Initiation of Phase II Study of AVP-786 for the Adjunctive Treatment of Major Depressive Disorder 3Avanir Pharmaceuticals Announces Initiation of Phase II Study of AVP-786 for the Adjunctive Treatment of Major Depressive Disorder 4Avanir Pharmaceuticals Announces Initiation of Phase II Study of AVP-786 for the Adjunctive Treatment of Major Depressive Disorder 5Avanir Pharmaceuticals Announces Initiation of Phase II Study of AVP-786 for the Adjunctive Treatment of Major Depressive Disorder 6
... BEIJING , July 7 /PRNewswire-Asia-FirstCall/ -- Concord ... CCM ), operator of,the largest network of radiotherapy and ... has filed its annual report for the fiscal year ended, ... Securities and Exchange,Commission on June 30, 2010 . The ...
... HARBIN, China , July 6 /PRNewswire-Asia-FirstCall/ -- ... or the,"Company"), a leading developer, manufacturer and marketer of ... other,health and nutritional products in the People,s Republic ... the Global Hunter 2010 China Conference,on Tuesday, July ...
Cached Medicine Technology:Concord Medical Files 2009 Annual Report on Form 20-F 2Weikang Bio-Technology to Present at Global Hunter 2010 China Conference on July 13, 2010 2Weikang Bio-Technology to Present at Global Hunter 2010 China Conference on July 13, 2010 3
(Date:8/27/2014)... Helix House, an Internet marketing firm that ... record demand for marketing services that take advantage of ... the country and throughout Arizona looking for innovative and ... turning to experienced Internet marketing firms like Helix House. ... features a dedicated and organized team of Internet marketers ...
(Date:8/27/2014)... August 27, 2014 Hastings and Hastings, ... greater Phoenix metropolitan area and all of Arizona is ... $160,000 on a $2 million settlement. This is ongoing ... those who have been injured through no fault of ... and time-consuming, however Hastings and Hastings is unrelenting as ...
(Date:8/27/2014)... 2014 According to market research report, ... Power Range (Micro, Low, Medium, High), Voltage (Low & ... Geography - Global Market Trends & Forecast to 2019” ... with an analysis and forecast of the market size. ... estimated $16.64 billion in 2014 to $22.73 billion by ...
(Date:8/27/2014)... 2014 Specialty Technical Publishers (STP) and ... Audit Protocol Consortium (IAPC) EHS audit protocol for Brazil ... the world use IAPC EHS audit protocols to understand ... collect, share, archive, and export audit findings in a ... prepared by AECOM in partnership with STP and focus ...
(Date:8/27/2014)... (PRWEB) August 27, 2014 Main Street Dental ... announcing its advice on how long a toothbrush can be ... best oral care for teeth and gums. , “Replacing a ... fairly regular basis," says Dr. Harvey Schwartz, owner of Main ... every three to four months." , Dr. Schwartz explains that ...
Breaking Medicine News(10 mins):Health News:Helix House Reports Record Demand For Marketing Services That Take Advantage Of Social Media 2Health News:Helix House Reports Record Demand For Marketing Services That Take Advantage Of Social Media 3Health News:Hastings and Hastings Is Pleased To Report Having Saved A Client $166,700 On A Settlement Of $2,000,000 2Health News:Hastings and Hastings Is Pleased To Report Having Saved A Client $166,700 On A Settlement Of $2,000,000 3Health News:Variable Frequency Drives Market Worth $22.73 Billion by 2019 – New Report by MarketsandMarkets 2Health News:Specialty Technical Publishers and AECOM Publish Environmental, Health & Safety (EHS) Audit Protocol for Brazil (and the State of São Paulo) 2Health News:Specialty Technical Publishers and AECOM Publish Environmental, Health & Safety (EHS) Audit Protocol for Brazil (and the State of São Paulo) 3Health News:Specialty Technical Publishers and AECOM Publish Environmental, Health & Safety (EHS) Audit Protocol for Brazil (and the State of São Paulo) 4Health News:Main Street Dental Team, Unionville’s Most Innovative Dental Clinic, Advises on the Best Time to Replace a Toothbrush 2
... 2007 According to a study using a dynamic ... NASDAQ: SHPGY, TSX: SHQ) ulcerative colitis drug LIALDA (mesalamine) ... drugs active ingredient, 5-aminosalicyclic acid (5-ASA), is released over ... colon is the site of inflammation in ulcerative colitis. ...
... Humans may not be any more sensitive in detecting ... recently published in Journal of Vision, an online, free-access ... Ophthalmology (ARVO). , Dr Eric Hiris of St. Mary,s ... that although many papers on the subject begin with ...
... assistance,division of Recovery Resources Inc., is offering Cleveland-area ... October in,recognition of national Drug-Free Work Week (October ... effective drug free workplace program. The U.S. ... in an,effort to educate businesses about the importance ...
... LONDON, October 17 - With Photo ... Around the,World, Raising Awareness of Stroke and Funds for ... plc, and James Cracknell OBE,double Olympic gold medallist, today ... Stroke Association. The campaign aims to,highlight the positive benefits ...
... offered to 10,000 Medicare Choice PPO members at no additional ... ... 17 Effective January 1, 2008, Group,Health Incorporated (GHI) has announced that ... toll-free number to speak with,their own independent Personal Health Advocate (PHA) for ...
... cancer ... awareness walk, WASHINGTON, Oct. 17 In an effort ... of,water and a storage unit during the Annual Walk for Hope to Cure ... 2K or 5K walk or run,took place at the grounds of Cabin John ...
Cached Medicine News:Health News:LIALDA demonstrates prolonged release of mesalamine in an in vitro study using a simulated colon 2Health News:LIALDA demonstrates prolonged release of mesalamine in an in vitro study using a simulated colon 3Health News:AssistNow Offers Area Employers Complimentary Needs Assessment in Recognition of National Drug-Free Work Week 2Health News:James Cracknell Launches Siemens Stroke for Stroke Week 2Health News:James Cracknell Launches Siemens Stroke for Stroke Week 3Health News:James Cracknell Launches Siemens Stroke for Stroke Week 4Health News:GHI to Provide Independent Personal Health Advocate for Medicare Members 2
... Seal-Away CS and Alliance Catheter ... for the introduction of catheters ... sinus from a superior approach. ... Medical's outstanding peel-away introducer performance ...
... been a key participant in the area ... a decade. Previous Medtronic autotransfusion systems allowed ... as well as to determine requirements for ... plasma (PRP) for a small amount of ...
This unique hemostatic seal provides a simple option for beating heart CABG anastomoses, allowing you to use your own hand-suturing technique without the release of cerebral emboli associated with th...
... .018 Biliary Self-Expanding Stent System combines low-profile, high ... This .018" guide wire compatible stent system provides ... all diameters (5.0 - 10.0 mm). Now, with ... offered in five stent lengths (28, 38, 56, ...
Medicine Products: